Data / Form D filings / CARDEAS PHARMA Corp
CARDEAS PHARMA Corp: Form D filings
CARDEAS PHARMA Corp, a pharmaceuticals company in Seattle, WA, filed 7 Form D notices with the SEC between 2010 and 2015. The latest, on April 9, 2015, reports $37.5 million sold of a $37.5 million offering to 21 investors.
Find out what CARDEAS PHARMA Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2025 1ST AVENUE, SUITE 1200, Seattle, WA, 98121
- Phone
- (206) 973-1026
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1497414
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2015 | Amendment | $37,500,000 | $37,500,000 | $0 | 21 | May 17, 2013 | sec.gov |
| May 23, 2013 | New notice | $34,000,000 | $34,000,000 | $0 | 21 | May 17, 2013 | sec.gov |
| Sep 27, 2012 | Amendment | $10,535,985 | $10,527,201 | $8,784 | 12 | Dec 19, 2011 | sec.gov |
| Mar 16, 2012 | Amendment | $7,535,988 | $7,535,988 | $0 | 10 | Dec 19, 2011 | sec.gov |
| Dec 30, 2011 | New notice | $7,499,988 | $5,899,995 | $1,599,993 | 5 | Dec 19, 2011 | sec.gov |
| Feb 22, 2011 | New notice | $1,100,000 | $1,001,523 | $98,477 | 18 | Feb 10, 2011 | sec.gov |
| Aug 10, 2010 | New notice | $20,100 | $20,100 | $0 | 3 | Aug 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Bruce deGavre | Director | |
| Anthony Bruce Scullion | Director | |
| A. Bruce Montgomery | Executive Officer, Director, Promoter | |
| Peter Bruce Moldt | Director | |
| Kevin Bruce Kinsella | Director | |
| Melissa Yeager | Executive Officer, Promoter | |
| Aaron Bruce Davidson | Director |
Other pharmaceuticals companies in Washington that filed recently
- Aptevo Therapeutics Inc. $3.5 million · Aug 26, 2026
Every Form D from the week of Apr 6, 2015 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CARDEAS PHARMA Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.